Search

Andrea K. Mccollum

Examiner (ID: 11971, Phone: (571)272-4002 , Office: P/1646 )

Most Active Art Unit
1646
Art Unit(s)
1674, 1646
Total Applications
733
Issued Applications
360
Pending Applications
111
Abandoned Applications
301

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9204931 [patent_doc_number] => 20140004108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-02 [patent_title] => 'Methods for Modulation of Autophagy Through the Modulation of Autophagy-Enhancing Gene Products' [patent_app_type] => utility [patent_app_number] => 13/929036 [patent_app_country] => US [patent_app_date] => 2013-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 303 [patent_figures_cnt] => 303 [patent_no_of_words] => 33394 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13929036 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/929036
Methods for Modulation of Autophagy Through the Modulation of Autophagy-Enhancing Gene Products Jun 26, 2013 Abandoned
Array ( [id] => 9107585 [patent_doc_number] => 20130280717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-24 [patent_title] => 'METHOD TO DETERMINE EMBRYO AND OOCYTE QUALITY BASED ON CERAMIDASE' [patent_app_type] => utility [patent_app_number] => 13/922995 [patent_app_country] => US [patent_app_date] => 2013-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8556 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13922995 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/922995
METHOD TO DETERMINE EMBRYO AND OOCYTE QUALITY BASED ON CERAMIDASE Jun 19, 2013 Abandoned
Array ( [id] => 12390900 [patent_doc_number] => 09964543 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-08 [patent_title] => Selection of medicaments that modulate the function and activity of interleukin 13 [patent_app_type] => utility [patent_app_number] => 13/921143 [patent_app_country] => US [patent_app_date] => 2013-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 20285 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13921143 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/921143
Selection of medicaments that modulate the function and activity of interleukin 13 Jun 17, 2013 Issued
Array ( [id] => 9262156 [patent_doc_number] => 20130344085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-26 [patent_title] => 'ANTI-PCSK9 ANTIBODIES, FORMULATIONS, DOSING, AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/918755 [patent_app_country] => US [patent_app_date] => 2013-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 51319 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13918755 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/918755
Anti-PCSK9 antibodies, formulations, dosing, and methods of use Jun 13, 2013 Issued
Array ( [id] => 10254938 [patent_doc_number] => 20150139935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-21 [patent_title] => 'SLEEP APNEA TREATMENT' [patent_app_type] => utility [patent_app_number] => 14/407786 [patent_app_country] => US [patent_app_date] => 2013-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12573 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14407786 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/407786
Sleep apnea treatment Jun 13, 2013 Issued
Array ( [id] => 9517764 [patent_doc_number] => 20140154257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-05 [patent_title] => 'Materials and methods for diagnosing and treating asthma and dietary Fru-AGEs related disorders including auto-immune and other diseases found to be associated with elevated RAGE. The specification describes methods to identify and make dietary derived advanced glycation end-products, known as Fru-AGEs, Fru-AGE-haptens, and Fru-AGE immune complexes, and to make monoclonal and polyclonal antibodies to this plurality of bio-molecules for use in immunoassays and for use as therapeutic agents' [patent_app_type] => utility [patent_app_number] => 13/908750 [patent_app_country] => US [patent_app_date] => 2013-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20121 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13908750 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/908750
Materials and methods for diagnosing and treating asthma and dietary Fru-AGEs related disorders including auto-immune and other diseases found to be associated with elevated RAGE. The specification describes methods to identify and make dietary derived advanced glycation end-products, known as Fru-AGEs, Fru-AGE-haptens, and Fru-AGE immune complexes, and to make monoclonal and polyclonal antibodies to this plurality of bio-molecules for use in immunoassays and for use as therapeutic agents Jun 2, 2013 Abandoned
Array ( [id] => 12044582 [patent_doc_number] => 09822176 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-21 [patent_title] => 'IL-3 antibodies and their use in diagnosis and treatment of diseases or malfunctions associated with elevated levels of IL-3' [patent_app_type] => utility [patent_app_number] => 14/400954 [patent_app_country] => US [patent_app_date] => 2013-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 15350 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14400954 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/400954
IL-3 antibodies and their use in diagnosis and treatment of diseases or malfunctions associated with elevated levels of IL-3 May 28, 2013 Issued
Array ( [id] => 10254944 [patent_doc_number] => 20150139941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-21 [patent_title] => 'COMBINED THERAPY AND PROPHYLAXIS FOR GENITAL TRACT INFECTIONS' [patent_app_type] => utility [patent_app_number] => 14/404197 [patent_app_country] => US [patent_app_date] => 2013-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5850 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14404197 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/404197
Combined therapy and prophylaxis for genital tract infections May 28, 2013 Issued
13/903972 Method for Analyzing Apoptosis Inducing Factor-2 May 27, 2013 Abandoned
Array ( [id] => 9602577 [patent_doc_number] => 20140199259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-17 [patent_title] => 'STABILIZED LIQUID FORMULATION' [patent_app_type] => utility [patent_app_number] => 13/903584 [patent_app_country] => US [patent_app_date] => 2013-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11304 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13903584 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/903584
STABILIZED LIQUID FORMULATION May 27, 2013 Abandoned
Array ( [id] => 11778154 [patent_doc_number] => 09387189 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-12 [patent_title] => 'Antibiotic composition comprising a chemotactic agent and a nutrient dispersion' [patent_app_type] => utility [patent_app_number] => 13/899980 [patent_app_country] => US [patent_app_date] => 2013-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2428 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13899980 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/899980
Antibiotic composition comprising a chemotactic agent and a nutrient dispersion May 21, 2013 Issued
Array ( [id] => 10255013 [patent_doc_number] => 20150140010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-21 [patent_title] => 'METHODS FOR DIAGNOSING AND TREATING FOCAL SEGMENTAL GLOMERULOSCLEROSIS' [patent_app_type] => utility [patent_app_number] => 14/402539 [patent_app_country] => US [patent_app_date] => 2013-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12712 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14402539 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/402539
METHODS FOR DIAGNOSING AND TREATING FOCAL SEGMENTAL GLOMERULOSCLEROSIS May 21, 2013 Abandoned
Array ( [id] => 9204930 [patent_doc_number] => 20140004107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-02 [patent_title] => 'ST2 ANTIGEN BINDING PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/897096 [patent_app_country] => US [patent_app_date] => 2013-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 56821 [patent_no_of_claims] => 154 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13897096 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/897096
ST2 antigen binding proteins May 16, 2013 Issued
Array ( [id] => 10097155 [patent_doc_number] => 09133458 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-15 [patent_title] => 'Methods for the treatment of hepatitis B and hepatitis D infections' [patent_app_type] => utility [patent_app_number] => 13/896421 [patent_app_country] => US [patent_app_date] => 2013-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16281 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 41 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13896421 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/896421
Methods for the treatment of hepatitis B and hepatitis D infections May 16, 2013 Issued
Array ( [id] => 10255010 [patent_doc_number] => 20150140008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-21 [patent_title] => 'USES OF CXCL17, A NOVEL CHEMOKINE MARKER OF HUMAN LUNG AND GASTROINTESTINAL DISEASE' [patent_app_type] => utility [patent_app_number] => 14/398053 [patent_app_country] => US [patent_app_date] => 2013-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10544 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14398053 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/398053
USES OF CXCL17, A NOVEL CHEMOKINE MARKER OF HUMAN LUNG AND GASTROINTESTINAL DISEASE May 2, 2013 Abandoned
Array ( [id] => 10608153 [patent_doc_number] => 09328174 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-03 [patent_title] => 'Chemokine receptor binding polypeptides' [patent_app_type] => utility [patent_app_number] => 13/886530 [patent_app_country] => US [patent_app_date] => 2013-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 5 [patent_no_of_words] => 45376 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13886530 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/886530
Chemokine receptor binding polypeptides May 2, 2013 Issued
Array ( [id] => 9338371 [patent_doc_number] => 20140065153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-06 [patent_title] => 'Methods for Treating Hair Loss Disorders' [patent_app_type] => utility [patent_app_number] => 13/886252 [patent_app_country] => US [patent_app_date] => 2013-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 107 [patent_figures_cnt] => 107 [patent_no_of_words] => 74588 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13886252 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/886252
Methods for treating hair loss disorders May 1, 2013 Issued
Array ( [id] => 10911724 [patent_doc_number] => 20140314741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-23 [patent_title] => 'Human Antibody against Interleukin-20 and Treatment for Inflammatory Diseases' [patent_app_type] => utility [patent_app_number] => 13/865671 [patent_app_country] => US [patent_app_date] => 2013-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3093 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13865671 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/865671
Human Antibody against Interleukin-20 and Treatment for Inflammatory Diseases Apr 17, 2013 Abandoned
Array ( [id] => 9053988 [patent_doc_number] => 20130251702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-26 [patent_title] => 'METHOD FOR SCREENING COMPOUNDS FOR TREATING SEPSIS TARGETING NOD2 SIGNALLING PATHWAY AND COMPOSITION FOR TREATING SEPSIS COMPRISING NOD2 SIGNALLING PATHWAY INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/848286 [patent_app_country] => US [patent_app_date] => 2013-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 9972 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13848286 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/848286
METHOD FOR SCREENING COMPOUNDS FOR TREATING SEPSIS TARGETING NOD2 SIGNALLING PATHWAY AND COMPOSITION FOR TREATING SEPSIS COMPRISING NOD2 SIGNALLING PATHWAY INHIBITORS Mar 20, 2013 Abandoned
Array ( [id] => 10281649 [patent_doc_number] => 20150166646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-18 [patent_title] => 'Methods and Compositions for Treating or Diagnosing Melanoma' [patent_app_type] => utility [patent_app_number] => 14/407607 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 24874 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14407607 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/407607
Methods and Compositions for Treating or Diagnosing Melanoma Mar 14, 2013 Abandoned
Menu